S&P 500   3,633.64 (+1.57%)
DOW   30,031.24 (+1.49%)
QQQ   294.72 (+1.49%)
AAPL   115.60 (+1.54%)
MSFT   213.26 (+1.50%)
FB   277.39 (+3.34%)
GOOGL   1,762.03 (+2.00%)
AMZN   3,120.03 (+0.70%)
TSLA   557.04 (+6.74%)
NVDA   518.38 (-1.37%)
BABA   279.71 (+3.55%)
CGC   26.98 (+9.14%)
GE   10.47 (+3.97%)
MU   63.72 (-0.72%)
AMD   85.06 (-0.29%)
T   29.22 (+2.10%)
NIO   53.58 (-3.25%)
F   9.42 (+6.32%)
ACB   9.12 (+27.02%)
NFLX   483.73 (+1.49%)
GILD   60.47 (+0.97%)
BA   218.98 (+3.52%)
DIS   151.68 (+3.90%)
S&P 500   3,633.64 (+1.57%)
DOW   30,031.24 (+1.49%)
QQQ   294.72 (+1.49%)
AAPL   115.60 (+1.54%)
MSFT   213.26 (+1.50%)
FB   277.39 (+3.34%)
GOOGL   1,762.03 (+2.00%)
AMZN   3,120.03 (+0.70%)
TSLA   557.04 (+6.74%)
NVDA   518.38 (-1.37%)
BABA   279.71 (+3.55%)
CGC   26.98 (+9.14%)
GE   10.47 (+3.97%)
MU   63.72 (-0.72%)
AMD   85.06 (-0.29%)
T   29.22 (+2.10%)
NIO   53.58 (-3.25%)
F   9.42 (+6.32%)
ACB   9.12 (+27.02%)
NFLX   483.73 (+1.49%)
GILD   60.47 (+0.97%)
BA   218.98 (+3.52%)
DIS   151.68 (+3.90%)
S&P 500   3,633.64 (+1.57%)
DOW   30,031.24 (+1.49%)
QQQ   294.72 (+1.49%)
AAPL   115.60 (+1.54%)
MSFT   213.26 (+1.50%)
FB   277.39 (+3.34%)
GOOGL   1,762.03 (+2.00%)
AMZN   3,120.03 (+0.70%)
TSLA   557.04 (+6.74%)
NVDA   518.38 (-1.37%)
BABA   279.71 (+3.55%)
CGC   26.98 (+9.14%)
GE   10.47 (+3.97%)
MU   63.72 (-0.72%)
AMD   85.06 (-0.29%)
T   29.22 (+2.10%)
NIO   53.58 (-3.25%)
F   9.42 (+6.32%)
ACB   9.12 (+27.02%)
NFLX   483.73 (+1.49%)
GILD   60.47 (+0.97%)
BA   218.98 (+3.52%)
DIS   151.68 (+3.90%)
S&P 500   3,633.64 (+1.57%)
DOW   30,031.24 (+1.49%)
QQQ   294.72 (+1.49%)
AAPL   115.60 (+1.54%)
MSFT   213.26 (+1.50%)
FB   277.39 (+3.34%)
GOOGL   1,762.03 (+2.00%)
AMZN   3,120.03 (+0.70%)
TSLA   557.04 (+6.74%)
NVDA   518.38 (-1.37%)
BABA   279.71 (+3.55%)
CGC   26.98 (+9.14%)
GE   10.47 (+3.97%)
MU   63.72 (-0.72%)
AMD   85.06 (-0.29%)
T   29.22 (+2.10%)
NIO   53.58 (-3.25%)
F   9.42 (+6.32%)
ACB   9.12 (+27.02%)
NFLX   483.73 (+1.49%)
GILD   60.47 (+0.97%)
BA   218.98 (+3.52%)
DIS   151.68 (+3.90%)
Log in
OTCMKTS:DCTHD

Delcath Systems Stock Forecast, Price & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
$3.00
0.00 (0.00 %)
(As of 05/29/2018)
Add
Compare
Today's Range
$3.00
Now: $3.00
$3.14
50-Day Range N/A
52-Week Range
$1.22
Now: $3.00
$63,000.00
Volume12,654 shs
Average Volume771 shs
Market Capitalization$120,000.00
P/E RatioN/A
Dividend YieldN/A
Beta-0.03
Delcath Systems, Inc. is a late-stage clinical development company with early commercial activity in Europe focused on cancers of the liver. The Company is a specialty pharmaceutical and medical device company developing its product, Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System (Melphalan/HDS). The Company's system delivers and filters melphalan hydrochloride, which is marketed as a device under the trade name Delcath Hepatic CHEMOSAT Delivery System for Melphalan (CHEMOSAT). The Company's focus is on the execution of the clinical development program (CDP) in ocular melanoma liver metastases (mOM), intrahepatic cholangiocarncinoma (ICC), hepatocellular carcinoma (HCC or primary liver) and other cancers that are metastatic to the liver.
Read More
Delcath Systems logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.50 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:DCTHD
Previous SymbolNASDAQ:DCTH
CUSIPN/A
CIKN/A
Phone212-489-2100
EmployeesN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$3.41 million
Book Value($1,036.00) per share

Profitability

Net Income$-19,220,000.00
Net Margins-1,546.38%

Miscellaneous

Market Cap$120,000.00
Next Earnings DateN/A
OptionableNot Optionable

Receive DCTHD News and Ratings via Email

Sign-up to receive the latest news and ratings for DCTHD and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Delcath Systems (OTCMKTS:DCTHD) Frequently Asked Questions

What stocks does MarketBeat like better than Delcath Systems?

Wall Street analysts have given Delcath Systems a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Delcath Systems wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How were Delcath Systems' earnings last quarter?

Delcath Systems, Inc. (OTCMKTS:DCTHD) released its quarterly earnings results on Friday, November, 11th. The medical device company reported ($231.00) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($1,151.50) by $920.50. The medical device company earned $0.44 million during the quarter. During the same quarter in the prior year, the company earned ($686.00) earnings per share.
View Delcath Systems' earnings history
.

When did Delcath Systems' stock split? How did Delcath Systems' stock split work?

Shares of Delcath Systems reverse split on the morning of Monday, November 6th 2017. The 1-350 reverse split was announced on Friday, November 3rd 2017. The number of shares owned by shareholders was adjusted after the closing bell on Friday, November 3rd 2017. An investor that had 100 shares of Delcath Systems stock prior to the reverse split would have 0 shares after the split.

Who are some of Delcath Systems' key competitors?

Who are Delcath Systems' key executives?

Delcath Systems' management team includes the following people:
  • Roger G. Stoll Ph.D., Chairman of the Board (Age 74)
  • Jennifer K. Simpson Ph.D., President, Chief Executive Officer, Director (Age 48)
  • Barbra C. Keck, Chief Financial Officer, Secretary (Age 39)
  • John Purpura, Executive Vice President - Global Head of Operations (Age 55)
  • Simon C. Pedder Ph.D., Director (Age 56)
  • William Dodge Rueckert, Independent Director (Age 64)
  • Marco Taglietti M.D., Independent Director (Age 57)

What is Delcath Systems' stock symbol?

Delcath Systems trades on the OTCMKTS under the ticker symbol "DCTHD."

What is Delcath Systems' stock price today?

One share of DCTHD stock can currently be purchased for approximately $3.00.

How big of a company is Delcath Systems?

Delcath Systems has a market capitalization of $120,000.00 and generates $3.41 million in revenue each year.

What is Delcath Systems' official website?

The official website for Delcath Systems is www.delcath.com.

How can I contact Delcath Systems?

Delcath Systems' mailing address is 1633 BROADWAY SUITE 22C, NEW YORK NY, 10019. The medical device company can be reached via phone at 212-489-2100 or via email at [email protected]

This page was last updated on 11/24/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.